Advancing global health innovation through Europe-Africa collaboration

Europe’s health security and strategic autonomy depend on its ability to prevent, detect and respond to infectious disease threats emerging within or outside its borders. Climate change, antimicrobial resistance and geopolitical instability are intensifying these risks, with consequences for European public health, economic stability and competitiveness. As the 10th EU Framework Programme for Research and Innovation (FP10) and other funding frameworks take shape, sustained investment in instruments that strengthen Europe’s and the world’s preparedness, scientific leadership and international partnerships is essential. Over more than two decades, PDPs have worked with partners under EDCTP to deliver advances in global health research and development. The combination of EU funding through EDCTP with PDPs’ technical expertise, product pipelines, global partner networks, and ability to mobilize additional funding has accelerated the development of health innovations for urgent and high-burden infectious diseases, multiplying the impact of the initial public investment. This has supported progress in TB, malaria, HIV/AIDS, bacterial infections and neglected tropical diseases, helping move candidate medicines, vaccines and diagnostics towards regulatory approval and policy uptake. Continued investment in EDCTP under FP10 and other EU funding frameworks is essential to safeguard Europe’s health security, sustain its scientific and innovation leadership and ensure that Europe and the European Union remain a credible and capable partner in global health. Read the report to see the full scope of EDCTP-PDP collaboration in action and understand how the EU can advance on its priorities through sustained investment in EDCTP.